Nalbuphine Hci 51662-1418-01
- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection, Solution
- Route
- Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 29, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA070918
Need to source Nalbuphine Hci? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nalbuphine Hydrochloride | 20 mg/mL |
Drug Class
Competitive Opioid Antagonists [MoA]Opioid Agonist/Antagonist [EPC]Partial Opioid Agonists [MoA]
Selected Package
51662-1418-01Selected1 VIAL, MULTI-DOSE in 1 CARTON (51662-1418-1) / 10 mL in 1 VIAL, MULTI-DOSE